(Q37779806)

23 August 2017

1 reference

title

Ticagrelor for the treatment of arterial thrombosis (English)

1 reference

23 August 2017

0 references

2

Dean J Kereiakes

1 reference

23 August 2017

1

Paul A Gurbel

1 reference

23 August 2017

Udaya S Tantry

3

1 reference

PubMed ID

20707759

23 August 2017

language of work or name

English

0 references

publication date

1 September 2010

1 reference

Expert Opinion on Pharmacotherapy

23 August 2017

1 reference

23 August 2017

11

1 reference

23 August 2017

13

1 reference

23 August 2017

2251-2259

1 reference

Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes.

23 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

The role of ADP receptors in platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

Delayed thrombin-induced platelet-fibrin clot generation by clopidogrel: a new dose-related effect demonstrated by thrombelastography in patients undergoing coronary artery stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

The rationale for and comparisons of different antiplatelet treatments in acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

Prasugrel: a critical comparison with clopidogrel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

Comparison of ticagrelor and thienopyridine P2Y(12) binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis/hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

Ticagrelor binds to human P2Y(12) independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

Ticagrelor--is there need for a new player in the antiplatelet-therapy field?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

Role of adenosine as adjunctive therapy in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.511175

10.1517/14656566.2010.511175

21 January 2018

Identifiers

DOI

1 reference

release_5sncjxceprgkzpmbzyc2rmfc7y

23 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5sncjxceprgkzpmbzyc2rmfc7y

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

20707759

1 reference

PubMed ID

20707759